143 related articles for article (PubMed ID: 15571267)
1. Genetic determinants of the pre- and post-azathioprine therapy thiopurine methyltransferase activity phenotype.
Arenas M; Duley JA; Ansari A; Shobowale-Bakre EA; Fairbanks L; Soon SY; Sanderson J; Marinaki AM
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1403-5. PubMed ID: 15571267
[TBL] [Abstract][Full Text] [Related]
2. Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European population.
Spire-Vayron de la Moureyre C; Debuysere H; Mastain B; Vinner E; Marez D; Lo Guidice JM; Chevalier D; Brique S; Motte K; Colombel JF; Turck D; Noel C; Flipo RM; Pol A; Lhermitte M; Lafitte JJ; Libersa C; Broly F
Br J Pharmacol; 1998 Oct; 125(4):879-87. PubMed ID: 9831928
[TBL] [Abstract][Full Text] [Related]
3. The role of genetic variation in thiopurine methyltransferase activity and the efficacy and/or side effects of azathioprine therapy in dermatologic patients.
Snow JL; Gibson LE
Arch Dermatol; 1995 Feb; 131(2):193-7. PubMed ID: 7857117
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a variable number tandem repeat region in the thiopurine S-methyltransferase gene promoter.
Spire-Vayron de la Moureyre C; Debuysère H; Fazio F; Sergent E; Bernard C; Sabbagh N; Marez D; Lo Guidice JM; D'halluin JC; Broly F
Pharmacogenetics; 1999 Apr; 9(2):189-98. PubMed ID: 10376766
[TBL] [Abstract][Full Text] [Related]
5. The impact of thiopurine S-methyltransferase polymorphisms on azathioprine dose 1 year after renal transplantation.
Fabre MA; Jones DC; Bunce M; Morris PJ; Friend PJ; Welsh KI; Marshall SE
Transpl Int; 2004 Oct; 17(9):531-9. PubMed ID: 15349717
[TBL] [Abstract][Full Text] [Related]
6. Thiopurine methyltransferase gene polymorphisms and activity in Chinese patients with inflammatory bowel disease treated with azathioprine.
Zhu Q; Cao Q
Chin Med J (Engl); 2012 Oct; 125(20):3665-70. PubMed ID: 23075721
[TBL] [Abstract][Full Text] [Related]
7. Thiopurine methyltransferase polymorphic tandem repeat: genotype-phenotype correlation analysis.
Yan L; Zhang S; Eiff B; Szumlanski CL; Powers M; O'Brien JF; Weinshilboum RM
Clin Pharmacol Ther; 2000 Aug; 68(2):210-9. PubMed ID: 10976552
[TBL] [Abstract][Full Text] [Related]
8. Thiopurine methyltransferase gene polymorphisms in Chinese patients with inflammatory bowel disease.
Cao Q; Zhu Q; Shang Y; Gao M; Si J
Digestion; 2009; 79(1):58-63. PubMed ID: 19252404
[TBL] [Abstract][Full Text] [Related]
9. Relevance of thiopurine methyltransferase status in rheumatology patients receiving azathioprine.
Clunie GP; Lennard L
Rheumatology (Oxford); 2004 Jan; 43(1):13-8. PubMed ID: 14566029
[TBL] [Abstract][Full Text] [Related]
10. Cat red blood cell thiopurine S-methyltransferase: companion animal pharmacogenetics.
Salavaggione OE; Yang C; Kidd LB; Thomae BA; Pankratz VS; Trepanier LA; Weinshilboum RM
J Pharmacol Exp Ther; 2004 Feb; 308(2):617-26. PubMed ID: 14610243
[TBL] [Abstract][Full Text] [Related]
11. The clinical impact of thiopurine methyltransferase polymorphisms on thiopurine treatment.
Coulthard SA; Matheson EC; Hall AG; Hogarth LA
Nucleosides Nucleotides Nucleic Acids; 2004 Oct; 23(8-9):1385-91. PubMed ID: 15571264
[TBL] [Abstract][Full Text] [Related]
12. Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription.
Fargher EA; Tricker K; Newman W; Elliott R; Roberts SA; Shaffer JL; Bruce I; Payne K
J Clin Pharm Ther; 2007 Apr; 32(2):187-95. PubMed ID: 17381669
[TBL] [Abstract][Full Text] [Related]
13. [Association between metabolic enzyme genotype of azathioprine and drug tolerance in patients with rheumatic diseases].
Zhan ZP; Liang LQ; Yang XY; Wang YX; Huang M; Li H
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(25):1734-7. PubMed ID: 17919375
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of polymorphism and low activity of thiopurine methyltransferase in patients with inflammatory bowel disease.
Larussa T; Suraci E; Lentini M; Nazionale I; Gallo L; Abenavoli L; Imeneo M; Costanzo FS; Cuda G; Luzza F
Eur J Intern Med; 2012 Apr; 23(3):273-7. PubMed ID: 22385887
[TBL] [Abstract][Full Text] [Related]
15. Mistaken identity: misclassification of TPMT phenotype following blood transfusion.
Cheung ST; Allan RN
Eur J Gastroenterol Hepatol; 2003 Nov; 15(11):1245-7. PubMed ID: 14560161
[TBL] [Abstract][Full Text] [Related]
16. Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism.
Boonsrirat U; Angsuthum S; Vannaprasaht S; Kongpunvijit J; Hirankarn N; Tassaneeyakul W; Avihingsanon Y
Lupus; 2008 Feb; 17(2):132-4. PubMed ID: 18250137
[TBL] [Abstract][Full Text] [Related]
17. Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study.
Gisbert JP; Luna M; Maté J; González-Guijarro L; Cara C; Pajares JM
Hepatogastroenterology; 2006; 53(69):399-404. PubMed ID: 16795981
[TBL] [Abstract][Full Text] [Related]
18. Clinical use and practical application of TPMT enzyme and 6-mercaptopurine metabolite monitoring in IBD.
Seidman EG
Rev Gastroenterol Disord; 2003; 3 Suppl 1():S30-8. PubMed ID: 12684587
[TBL] [Abstract][Full Text] [Related]
19. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
[TBL] [Abstract][Full Text] [Related]
20. Genetic determinants of the thiopurine methyltransferase intermediate activity phenotype in British Asians and Caucasians.
Marinaki AM; Arenas M; Khan ZH; Lewis CM; Shobowale-Bakre el-M; Escuredo E; Fairbanks LD; Mayberry JF; Wicks AC; Ansari A; Sanderson J; Duley JA
Pharmacogenetics; 2003 Feb; 13(2):97-105. PubMed ID: 12563179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
